CN103721215A - Chinese medicinal composition for treating hyperlipemia - Google Patents
Chinese medicinal composition for treating hyperlipemia Download PDFInfo
- Publication number
- CN103721215A CN103721215A CN201210387694.XA CN201210387694A CN103721215A CN 103721215 A CN103721215 A CN 103721215A CN 201210387694 A CN201210387694 A CN 201210387694A CN 103721215 A CN103721215 A CN 103721215A
- Authority
- CN
- China
- Prior art keywords
- radix
- rhizoma
- medicinal composition
- chinese medicinal
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a Chinese medicinal composition for treating hyperlipemia. The Chinese medicinal composition is prepared from the following raw materials by weight part: 12-15 of radix bupleuri; 9-12 of Scutellaria baicalensis; 9-15 of Paeonia lactiflora; 9-15 of pinellia ternate; 9-15 of Immature Bitter Orange; 6-10 of rhubarb; 15-20 of fresh ginger; 4-10 of Chinese dates; 10-20 of Cirsium japonicum; 5-20 of bighead atractylodes rhizome; 5-20 of Salvia Miltiorrhiza; 5-15 of eucommia; and 5-15 of finger citron. The Chinese medicinal composition for treating hyperlipemia provided by the invention has the advantages of small side effect and high cure rate.
Description
Technical field
The present invention relates to the field of Chinese medicines, relate in particular to a kind of Chinese medicine composition that is used for the treatment of hyperlipidemia.
Background technology
Hyperlipemia refers to that the content of one or several lipid components of human plasma exceedes normal peak limit.Primary disease occupies very consequence in Nutrition and Metabolism illness, is to cause one of atherosclerotic principal element, with being related closely of hypertension, coronary heart disease and cerebrovascular, is regarded as one of three large factor of coronary heart disease.In China, this disease is unrare, and the trend that its prevalence and mortality rate increase in addition year by year in recent years, in being especially more common in, old people.The primary disease constitutional cause of disease is not bright, has family history and hereditary history more.Though modern medicine has multiple fat-reducing medicament, there are side effect and curative effect unstable more.
Summary of the invention
The technical problem to be solved in the present invention is for above-mentioned defect, provides a kind of.
For achieving the above object, the adoptable technical scheme of the present invention is:
Be used for the treatment of a Chinese medicine composition for hyperlipidemia, it is made by the raw material of following parts by weight: Radix Bupleuri 12-15; Radix Scutellariae 9-12; Radix Paeoniae 9-15; Rhizoma Pinelliae 9-15; Fructus Aurantii Immaturus 9-15; Radix Et Rhizoma Rhei 6-10; Rhizoma Zingiberis Recens 15-20; Fructus Jujubae 4-10; Radix Cirsii Japonici 10-20; Rhizoma Atractylodis Macrocephalae 5-20; Radix Salviae Miltiorrhizae 5-20; Cortex Eucommiae 5-15; Fructus Citri Sarcodactylis 5-15.
Preferably, the described Chinese medicine composition that is used for the treatment of hyperlipidemia is made by the raw material of following parts by weight: Radix Bupleuri 12; Radix Scutellariae 9; Radix Paeoniae 9; The Rhizoma Pinelliae 9; Fructus Aurantii Immaturus 9; Radix Et Rhizoma Rhei 6; Rhizoma Zingiberis Recens 15; Fructus Jujubae 4; Radix Cirsii Japonici 10; The Rhizoma Atractylodis Macrocephalae 5; Radix Salviae Miltiorrhizae 5; The Cortex Eucommiae 5; Fructus Citri Sarcodactylis 5.
The Chinese medicine composition that is used for the treatment of hyperlipidemia of the present invention has advantages of that cure rate is high, is difficult for repeatedly and has no side effect.
The specific embodiment
Embodiment 1
According to following parts by weight, take raw material: Radix Bupleuri 12g; Radix Scutellariae 9g; Radix Paeoniae 9g; Rhizoma Pinelliae 9g; Fructus Aurantii Immaturus 9g; Radix Et Rhizoma Rhei 6g; Rhizoma Zingiberis Recens 15g; Fructus Jujubae 4g; Radix Cirsii Japonici 10g; Rhizoma Atractylodis Macrocephalae 5g; Radix Salviae Miltiorrhizae 5g; Cortex Eucommiae 5g; Fructus Citri Sarcodactylis 5g.1 dose of every day, adds water 500ml, decocts to 300ml point 2 clothes.
Embodiment 2
According to following parts by weight, take raw material: Radix Bupleuri 15g; Radix Scutellariae 12g; Radix Paeoniae 15g; Rhizoma Pinelliae 15g; Fructus Aurantii Immaturus 15g; Radix Et Rhizoma Rhei 10g; Rhizoma Zingiberis Recens 20g; Fructus Jujubae 10g; Radix Cirsii Japonici 20g; Rhizoma Atractylodis Macrocephalae 20g; Radix Salviae Miltiorrhizae 20g; Cortex Eucommiae 15g; Fructus Citri Sarcodactylis 15g.1 dose of every day, adds water 500ml, decocts to 300ml point 2 clothes.
Claims (2)
1. a Chinese medicine composition that is used for the treatment of hyperlipidemia, is characterized in that, it is made by the raw material of following parts by weight: Radix Bupleuri 12-15; Radix Scutellariae 9-12; Radix Paeoniae 9-15; Rhizoma Pinelliae 9-15; Fructus Aurantii Immaturus 9-15; Radix Et Rhizoma Rhei 6-10; Rhizoma Zingiberis Recens 15-20; Fructus Jujubae 4-10; Radix Cirsii Japonici 10-20; Rhizoma Atractylodis Macrocephalae 5-20; Radix Salviae Miltiorrhizae 5-20; Cortex Eucommiae 5-15; Fructus Citri Sarcodactylis 5-15.
2. the Chinese medicine composition that is used for the treatment of hyperlipidemia according to claim 1, is characterized in that, it is made by the raw material of following parts by weight: Radix Bupleuri 12; Radix Scutellariae 9; Radix Paeoniae 9; The Rhizoma Pinelliae 9; Fructus Aurantii Immaturus 9; Radix Et Rhizoma Rhei 6; Rhizoma Zingiberis Recens 15; Fructus Jujubae 4; Radix Cirsii Japonici 10; The Rhizoma Atractylodis Macrocephalae 5; Radix Salviae Miltiorrhizae 5; The Cortex Eucommiae 5; Fructus Citri Sarcodactylis 5.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210387694.XA CN103721215A (en) | 2012-10-15 | 2012-10-15 | Chinese medicinal composition for treating hyperlipemia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210387694.XA CN103721215A (en) | 2012-10-15 | 2012-10-15 | Chinese medicinal composition for treating hyperlipemia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103721215A true CN103721215A (en) | 2014-04-16 |
Family
ID=50445676
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210387694.XA Pending CN103721215A (en) | 2012-10-15 | 2012-10-15 | Chinese medicinal composition for treating hyperlipemia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103721215A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104435205A (en) * | 2014-11-10 | 2015-03-25 | 成都果睿医药科技有限公司 | Salvia-miltiorrhiza-containing pharmaceutical composition for reducing blood fat |
| CN113304235A (en) * | 2020-02-26 | 2021-08-27 | 北京重生医药科技有限公司 | Traditional Chinese medicine composition and preparation method and application thereof |
-
2012
- 2012-10-15 CN CN201210387694.XA patent/CN103721215A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104435205A (en) * | 2014-11-10 | 2015-03-25 | 成都果睿医药科技有限公司 | Salvia-miltiorrhiza-containing pharmaceutical composition for reducing blood fat |
| CN113304235A (en) * | 2020-02-26 | 2021-08-27 | 北京重生医药科技有限公司 | Traditional Chinese medicine composition and preparation method and application thereof |
| CN113304235B (en) * | 2020-02-26 | 2022-07-26 | 北京重生医药科技有限公司 | Traditional Chinese medicine composition and preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101569730A (en) | Traditional Chinese medicine tolnaftate | |
| CN103721215A (en) | Chinese medicinal composition for treating hyperlipemia | |
| CN101745092A (en) | Traditional Chinese medicine for treating infantile diarrhea | |
| CN101757419A (en) | Blood-nourishing skin lotion | |
| CN102988909A (en) | Rheumatoid bone rubbing wine | |
| CN104644776A (en) | Chinese patent medicine powder for the treatment of abnormal menstruation | |
| CN103721214A (en) | Traditional Chinese medicine composition used for treating Meniere's disease | |
| CN103386031A (en) | Drug for treating vascular dementia | |
| CN104623149A (en) | Traditional Chinese medicine formula for treating influenza A (H1N1) | |
| CN104367933A (en) | Medicinal powder for treating liver cirrhosis and liver ascites | |
| CN102078495A (en) | Chinese traditional medicine for treating apoplexy | |
| CN102309648A (en) | Traditional Chinese medicine prescription for treating postpartum retention of lochia | |
| CN104524042A (en) | Traditional Chinese medicinal composition for treating alopecia | |
| CN102940805A (en) | Chinese medicament for treating coronary heart disease | |
| CN104694346A (en) | Medicinal wine for energy invigorating and spleen and stomach adjusting | |
| CN105169045A (en) | Traditional Chinese medicine decoction for treating pulmonary consumption with cough | |
| CN104740015A (en) | Traditional Chinese medicine composition for treating malaria | |
| CN104739958A (en) | Chinese medicinal composition for treating rheumatic fever | |
| CN101972312A (en) | Medicine for treating hepatitis | |
| CN105663668A (en) | Traditional Chinese medicine for treating diabetic complications and preparation method thereof | |
| CN103720952A (en) | Traditional Chinese medicine composition used for treating infantile diarrhea | |
| CN105497661A (en) | Traditional Chinese medicine formula for treating acne | |
| CN103690916A (en) | Traditional Chinese medicine decoction for treating infantile protracted pneumonia | |
| CN103041106A (en) | Traditional Chinese medicine composition for treating vitiligo | |
| CN103877173A (en) | Traditional Chinese medicine compound preparation for treating dermatopathy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140416 |